Teladoc Health Inc (TDOC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.49 is considered Undervalued compared with the five-year average of -26.79. The fair price of Teladoc Health Inc (TDOC) is between 10.30 to 11.05 according to relative valuation method. Compared to the current price of 5.10 USD , Teladoc Health Inc By Undervalued By 50.48%.

Relative Value

Fair Zone

10.30-11.05

Current Price：5.10

50.48%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Teladoc Health Inc (TDOC) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Teladoc Health Inc (TDOC) has a current Price-to-Book (P/B) ratio of 0.90. Compared to its 3-year average P/B ratio of 1.20, the current P/B ratio is approximately -25.45% higher. Relative to its 5-year average P/B ratio of 1.19, the current P/B ratio is about -24.28% higher. Teladoc Health Inc (TDOC) has a Forward Free Cash Flow (FCF) yield of approximately 22.39%. Compared to its 3-year average FCF yield of 15.44%, the current FCF yield is approximately 45.04% lower. Relative to its 5-year average FCF yield of 9.75%, the current FCF yield is about 129.67% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TDOC competitors is 2.61, providing a benchmark for relative valuation. Teladoc Health Inc Corp (TDOC.N) exhibits a P/S ratio of 0.49, which is -81.1% above the industry average. Given its robust revenue growth of 0.28%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TDOC increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TDOC in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TDOC currently overvalued or undervalued?

What is Teladoc Health Inc (TDOC) fair value?

TDOC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Teladoc Health Inc (TDOC) is between 10.30 to 11.05 according to relative valuation method.

How does TDOC's valuation metrics compare to the industry average?

The average P/S ratio for TDOC's competitors is 2.61, providing a benchmark for relative valuation. Teladoc Health Inc Corp (TDOC) exhibits a P/S ratio of 0.49, which is -81.10% above the industry average. Given its robust revenue growth of 0.28%, this premium appears unsustainable.

What is the current P/B ratio for Teladoc Health Inc (TDOC) as of Mar 04 2026?

As of Mar 04 2026, Teladoc Health Inc (TDOC) has a P/B ratio of 0.90. This indicates that the market values TDOC at 0.90 times its book value.

What is the current FCF Yield for Teladoc Health Inc (TDOC) as of Mar 04 2026?

As of Mar 04 2026, Teladoc Health Inc (TDOC) has a FCF Yield of 22.39%. This means that for every dollar of Teladoc Health Inc's market capitalization, the company generates 22.39 cents in free cash flow.

What is the current Forward P/E ratio for Teladoc Health Inc (TDOC) as of Mar 04 2026?

As of Mar 04 2026, Teladoc Health Inc (TDOC) has a Forward P/E ratio of -7.68. This means the market is willing to pay $-7.68 for every dollar of Teladoc Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Teladoc Health Inc (TDOC) as of Mar 04 2026?

As of Mar 04 2026, Teladoc Health Inc (TDOC) has a Forward P/S ratio of 0.49. This means the market is valuing TDOC at $0.49 for every dollar of expected revenue over the next 12 months.

TDOC Valuation